HIV and recent illicit drug use interact to affect verbal memory in women

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 1, 2013, Pages 67-76

  Meyer, Vanessa J ^a   Rubin, Leah H ^a   Martin, Eileen ^b   Weber, Kathleen M ^c   Cohen, Mardge H ^b,c   Golub, Elizabeth T ^d   Valcour, Victor ^e   Young, Mary A ^f   Crystal, Howard ^g   Anastos, Kathryn ^h   Aouizerat, Bradley E ^e,i   Milam, Joel ^j   Maki, Pauline M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c CORE Center/Cook County Health and Hospital System ^*  (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g Downstate Health Sciences University   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ School of Nursing   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

African American; cocaine; cognition; HIV; illicit drug use; women

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRAIN FUNCTION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SEROLOGY; STROOP TEST; VERBAL MEMORY;

ADULT; AFRICAN AMERICANS; AGED; COCAINE-RELATED DISORDERS; COGNITION; CRACK COCAINE; EXECUTIVE FUNCTION; FEMALE; HEROIN; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MEMORY; MIDDLE AGED; SEX FACTORS; STREET DRUGS; VERBAL LEARNING; YOUNG ADULT;

EID: 84876287478     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318289565c     Document Type: Article

References (96)

1. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. JNeurovirol. 2002;8:136-142.
2. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1:231-251.
3. Benedict RH, Mezhir JJ, Walsh K, et al. Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol. 2000;15:535-544.
4. Heaton RK, Velin RA, McCutchan JA, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56:8-17.
5. van Gorp WG, Rabkin JG, Ferrando SJ, et al. Neuropsychiatric predictors of return to work in HIV/AIDS. J Int Neuropsychol Soc. 2007;13: 80-89.
6. Cattie JE, Woods SP, Arce M, et al. Construct validity of the item-specific deficit approach to the California verbal learning test (2nd Ed) in HIV infection. Clin Neuropsychol. 2012;26:288-304.
7. Scott JC, Woods SP, Patterson KA, et al. Recency effects in HIV-associated dementia are characterized by deficient encoding. Neuropsychologia. 2006; 44:1336-1343.
8. Woods SP, Scott JC, Dawson MS, et al. Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol. 2005;20:1061-1071.
9. Beatty WW, Katzung VM, Moreland VJ, et al. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend. 1995;37:247-253.
10. Berry J, van Gorp WG, Herzberg DS, et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend. 1993;32:231-237.
11. Bolla KI, Funderburk FR, Cadet JL. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology. 2000;54: 2285-2292.
12. O'Malley S, Adamse M, Heaton RK, et al. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1992;18: 131-144.
13. Strickland TL, Mena I, Villanueva-Meyer J, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1993;5:419-427.
14. Darke S, Sims J, McDonald S, et al. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95:687-695.
15. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1999;11:361-369.
16. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci. 2004;24:11017-11022.
17. Grant S, Contoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia. 2000;38:1180-1187.
18. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002;67:41-51.
19. Aksenov MY, Aksenova MV, Nath A, et al. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology. 2006;27:217-228.
20. Aksenov MY, Hasselrot U, Wu G, et al. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res. 2003;987:1-9.
21. Bagasra O, Pomerantz RJ. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis. 1993;168:1157-1164.
22. Dhillon NK, Williams R, Peng F, et al. Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol. 2007;13: 483-495.
23. Fiala M, Eshleman AJ, Cashman J, et al. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J Neurovirol. 2005;11:281-291.
24. Fiala M, Gan XH, Zhang L, et al. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Adv Exp Med Biol. 1998;437:199-205.
25. Gekker G, Hu S, Wentland MP, et al. Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther. 2004;309:600-606.
26. Harrod SB, Mactutus CF, Fitting S, et al. Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine. Pharmacol Biochem Behav. 2008;90:723-729.
27. Kendall SL, Anderson CF, Nath A, et al. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182, 780 sensitive mechanism. BMC Neurosci. 2005;6:40.
28. Peterson PK, Gekker G, Chao CC, et al. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol. 1991;146:81-84.
29. Reynolds JL, Mahajan SD, Bindukumar B, et al. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res. 2006;1123:226-236.
30. Roth MD, Tashkin DP, Choi R, et al. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immuno-deficient mice implanted with human peripheral blood leukocytes. J Infect Dis. 2002;185:701-705.
31. Turchan J, Anderson C, Hauser KF, et al. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2001;2:3.
32. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS. 1999;13:1-22.
33. Gurwell JA, Nath A, Sun Q, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience. 2001;102:555-563.
34. Khurdayan VK, Buch S, El-Hage N, et al. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci. 2004;19:3171-3182.
35. Hu S, Sheng WS, Lokensgard JR, et al. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis. 2005;191:886-889.
36. Venkatesan A, Nath A, Ming GL, et al. Adult hippocampal neurogene-sis: regulation by HIV and drugs of abuse. Cell Mol Life Sci. 2007;64: 2120-2132.
37. Maki PM, Martin-Thormeyer E. HIV, cognition and women. Neuropsy-chol Rev. 2009;19:204-214.
38. Lejuez CW, Bornovalova MA, Reynolds EK, et al. Risk factors in the relationship between gender and crack/cocaine. Exp Clin Psychopharma-col. 2007;15:165-175.
39. O'Brien MS, Anthony JC. Risk of becoming cocaine dependent: epide-miological estimates for the United States, 2000-2001. Neuropsycho-pharmacology. 2005;30:1006-1018.
40. Chen K, Kandel D. Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug Alcohol Depend. 2002;68:65-85.
41. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team NEnglJMed. 1994;331:1422-1427.
42. Baum MK, Rafie C, Lai S, et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2009;50:93-99.
43. Webber MP, Schoenbaum EE, Gourevitch MN, et al. A prospective study of HIV disease progression in female and male drug users. AIDS. 1999;13:257-262.
44. Cook JA, Burke-Miller JK, Cohen MH, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS. 2008;22:1355-1363.
45. Thorpe LE, Frederick M, Pitt J, et al. Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. J Acquir Immune Defic Syndr. 2004; 37:1423-1430.
46. Carey CL, Woods SP, Rippeth JD, et al. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004;18:234-248.
47. Hinkin CH, Castellon SA, Hardy DJ, et al. Computerized and traditional stroop task dysfunction in HIV-1 infection. Neuropsychology. 1999;13: 306-316.
48. Martin EM, Novak RM, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc. 2004;10:298-300.
49. Moore DJ, Masliah E, Rippeth JD, et al. Cortical and subcortical neuro-degeneration is associated with HIV neurocognitive impairment. AIDS. 2006;20:879-887.
50. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26:759-778.
51. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12:1013-1019.
52. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117-125.
53. Maki P, Rubin LH, Cohen M, et al. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse HIV+ and HIV-women. Menopause. 2012;19:1215-1223.
54. Benedict RHB, Schretlen D, Groninger L, et al. Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43-55.
55. Comalli Jr PE, Wapner S, Werner H. Interference effects of Stroop color-word test in childhood, adulthood, and aging. J Genet Psychol. 1962;100:47-53.
56. Jastak S, Wilkinson GS, Jastak J. Wide Range Achievement Test-Revised. Indianapolis, IN: Jastak Associates Inc; 1984.
57. Manly JJ, Jacobs DM, Touradji P, et al. Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc. 2002;8:341-348.
58. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
59. Cherner M, Letendre S, Heaton RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology. 2005;64:1343-1347.
60. Durvasula RS, Miller EN, Myers HF, et al. Predictors of neuropsychological performance in HIV positive women. J Clin Exp Neuropsychol. 2001;23:149-163.
61. Goggin KJ, Zisook S, Heaton RK, et al. Neuropsychological performance of HIV-1 infected men with major depression. HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1997; 3:457-464.
62. Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005;19(suppl 3):S72-S78.
63. Manly JJ, Smith C, Crystal HA, et al. Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV-women: The Women's Interagency HIV Study (WIHS) Neurocognitive Substudy. J Clin Exp Neuropsychol. 2011;33:853-863.
64. Richardson JL, Nowicki M, Danley K, et al. Neuropsychological functioning in a cohort of HIV-and hepatitis C virus-infected women. AIDS. 2005;19:1659-1667.
65. Ryan EL, Morgello S, Isaacs K, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62:957-962.
66. Valcour V, Maki P, Bacchetti P, et al. Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: The Women's Interagency HIV Study. AIDS Res Hum Retroviruses. 2012;28:447-453.
67. Willenbring ML, Massey SH, Gardner MB. Helping patients who drink too much: an evidence-based guide for primary care clinicians. Am Fam Physician. 2009;80:44-50.
68. Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944-1950.
69. Martin-Thormeyer EM, Paul RH. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocog-nitive and neuroimaging features. Neuropsychol Rev. 2009;19:215-231.
70. Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10:1-14.
71. Chang L, Ernst T, Speck O, et al. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162:361-369.
72. Ances BM, Vaida F, Cherner M, et al. HIV and chronic methamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011; 6:409-419.
73. Durvasula RS, Myers HF, Satz P, et al. HIV-1, cocaine, and neuropsy-chological performance in African American men. J Int Neuropsychol Soc. 2000;6:322-335.
74. Gonzalez R, Jacobus J, Amatya AK, et al. Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence. Neuropsychology. 2008;22:776-786.
75. Martin EM, Nixon H, Pitrak DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Neuropsychol. 2007;29:496-504.
76. Martin EM, Pitrak DL, Rains N, et al. Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers. Neuropsychology. 2003;17:283-288.
77. Martin EM, Sullivan TS, Reed RA, et al. Auditory working memory in HIV-1 infection. J Int Neuropsychol Soc. 2001;7:20-26.
78. Martin EM, Pitrak DL, Weddington W, et al. Cognitive impulsivity and HIV serostatus in substance dependent males. J Int Neuropsychol Soc. 2004;10:931-938.
79. Mason KI, Campbell A, Hawkins P, et al. Neuropsychological functioning in HIV-positive African-American women with a history of drug use. J Natl Med Assoc. 1998;90:665-674.
80. Hanlon CA, Dufault DL, Wesley MJ, et al. Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl). 2011;218:681-692.
81. Di Sclafani V, Tolou-Shams M, Price LJ, et al. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend. 2002;66:161-171.
82. Gould RW, Gage HD, Nader MA. Effects of chronic cocaine self-administration on cognition and cerebral glucose utilization in Rhesus monkeys. Biol Psychiatry. 2012;72:856-863.
83. Meade CS, Conn NA, Skalski LM, et al. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. JBehav Med. 2011;34:128-138.
84. Byrd DA, Fellows RP, Morgello S, et al. Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr. 2011;58:154-162.
85. Levine AJ, Hardy DJ, Miller E, et al. The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol. 2006;28:29-42.
86. Woicik PA, Moeller SJ, Alia-Klein N, et al. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsycho- pharmacology. 2009;34:1112-1122.
87. Verdejo-Garcia AJ, Lopez-Torrecillas F, Aguilar de Arcos F, et al. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav. 2005;30:89-101.
88. Bolla K, Ernst M, Kiehl K, et al. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci. 2004;16: 456-464.
89. Franklin TR, Acton PD, Maldjian JA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry. 2002;51:134-142.
90. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14:169-177.
91. Volkow ND, Hitzemann R, Wang GJ, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse. 1992;11:184-190.
92. Volkow ND, Mullani N, Gould KL, et al. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry. 1988;152:641-648.
93. Delis DC, Peavy G, Heaton R, et al. Do patients with HIV-associated minor cognitive/motor disorder exhibit a "subcortical" memory profile? Evidence using the California Verbal Learning Test. Assessment. 1995;2:151-165.
94. Gongvatana A, Woods SP, Taylor MJ, et al. Semantic clustering inefficiency in HIV-associated dementia. J Neuropsychiatry Clin Neurosci. 2007;19:36-42.
95. Peavy G, Jacobs D, Salmon DP, et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol. 1994; 16:508-523.
96. Maki PM, Cohen MH, Weber K, et al. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology. 2009;72:1661-1668.